Skip to main content
. 2020 May 11;18:193. doi: 10.1186/s12967-020-02351-7

Table 5.

Perioperative NT-proBNP in patients with complete data sets of NT-proBNP Preop and POD1 or NT-proBNP Preop and POD3 and EuroSCORE II ≥ 4.15

Variables EuroSCORE II ≥ 4.15 (n = 81a/83b) Glutamate
(n = 41a/47b)
Control
(n = 37a/36b)
p-value
NT-proBNP Prea (ng•L−1) 1090 [460–2430] 980 [435–2057] 1340 [460–2910] 0.38
NT-proBNP POD1a (ng•L−1) 4390 [2950–6300] 3802 [2715–5570] 4690 [3060–6650] 0.19
Delta NT-proBNP POD1-Prea (ng•L−1) 2800 [1650–4760] 2653 [1540–3675] 3050 [2030–5560] 0.13
NT-proBNP Preb (ng•L−1) 970 [425–2345] 740 [395–1810] 1265 [465–2985] 0.10
NT-proBNP POD3b (ng•L−1) 6650 [3840–10,085] 5140 [3490–7423] 8220 [5339–14,550] 0.002
Delta NT-proBNP POD3-Preb (ng•L−1) 5210 [3115–8595] 3900 [2995–6260] 6745 [3455–12,686] 0.012

Data given as medians [interquartile range] or percentages (number)

Preop preoperative, POD postoperative day

aPatients with complete data sets of NT-proBNP Preop and POD1

bPatients with complete data sets of NT-proBNP Preop and POD3